US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 9.165
  • +0.085+0.94%
Trading Nov 21 14:25 ET
194.20MMarket Cap-1681P/E (TTM)

Enanta Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Jun 30, 2024
(Q2)Mar 31, 2024
(Q1)Dec 31, 2023
(FY)Sep 30, 2023
(Q4)Sep 30, 2023
(Q3)Jun 30, 2023
(Q2)Mar 31, 2023
(Q1)Dec 31, 2022
(FY)Sep 30, 2022
(Q4)Sep 30, 2022
Total revenue
-4.88%17.97M
-4.16%17.05M
-23.67%18M
-8.07%79.2M
-6.82%18.93M
-3.01%18.89M
-4.92%17.8M
-14.70%23.59M
-11.24%86.16M
-13.82%20.32M
Operating revenue
-4.88%17.97M
-4.16%17.05M
-23.67%18M
-8.07%79.2M
-6.82%18.93M
-3.01%18.89M
-4.92%17.8M
-14.70%23.59M
-11.24%86.16M
-13.82%20.32M
Cost of revenue
Gross profit
Operating expense
-24.19%42.16M
-12.97%49.82M
-1.32%52.89M
3.05%216.41M
5.48%49.96M
6.89%55.61M
8.91%57.25M
-7.68%53.6M
1.62%210M
-17.34%47.37M
Selling and administrative expenses
6.31%13.41M
3.32%14.24M
30.10%16.52M
16.28%52.89M
9.75%13.8M
-2.41%12.62M
31.52%13.78M
33.53%12.7M
39.79%45.48M
50.42%12.57M
-General and administrative expense
6.31%13.41M
3.32%14.24M
30.10%16.52M
16.28%52.89M
9.75%13.8M
-2.41%12.62M
31.52%13.78M
33.53%12.7M
39.79%45.48M
50.42%12.57M
Research and development costs
-33.14%28.74M
-18.14%35.59M
-11.08%36.37M
-0.61%163.52M
3.94%36.17M
9.97%42.99M
3.28%43.47M
-15.75%40.9M
-5.51%164.52M
-28.91%34.8M
Operating profit
34.12%-24.19M
16.95%-32.77M
-16.24%-34.89M
-10.79%-137.21M
-14.72%-31.03M
-12.82%-36.71M
-16.56%-39.45M
1.30%-30.01M
-13.02%-123.84M
19.80%-27.05M
Net non-operating interest income expense
-39.43%1.13M
-32.17%1.25M
-13.70%857K
294.91%6.21M
139.78%1.51M
375.57%1.87M
620.39%1.84M
993K
-22.17%1.57M
631K
Non-operating interest income
-9.80%3.49M
107.35%3.81M
332.83%4.3M
622.19%11.36M
639.14%4.66M
883.72%3.87M
620.39%1.84M
--993K
-22.17%1.57M
--631K
Non-operating interest expense
17.93%2.36M
--2.56M
--3.44M
--5.15M
--3.15M
--2M
--0
--0
--0
--0
Other net income (expense)
407.41%83K
Other non- operating income (expenses)
----
----
----
----
----
----
----
----
407.41%83K
----
Income before tax
33.84%-23.05M
16.20%-31.52M
-17.26%-34.03M
-7.21%-131M
-12.09%-29.52M
-8.39%-34.84M
-11.97%-37.61M
3.75%-29.02M
-13.58%-122.19M
21.14%-26.33M
Income tax
-109.36%-395K
-925.00%-363K
-1,729.41%-622K
751.50%2.82M
-10,171.43%-1.41M
1,044.30%4.22M
44K
5.56%-34K
98.49%-433K
100.16%14K
Net income
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
-54.13%-121.76M
-7.11%-26.35M
Net income continuous Operations
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
-54.13%-121.76M
-7.11%-26.35M
Minority interest income
Net income attributable to the parent company
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
-54.13%-121.76M
-7.11%-26.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
42.00%-22.66M
17.26%-31.16M
-15.25%-33.41M
-9.91%-133.82M
-6.68%-28.11M
-23.23%-39.07M
-12.10%-37.66M
3.75%-28.99M
-54.13%-121.76M
-7.11%-26.35M
Basic earnings per share
42.47%-1.07
17.88%-1.47
-13.67%-1.58
-7.95%-6.38
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
6.08%-1.39
-50.77%-5.91
-4.10%-1.27
Diluted earnings per share
42.47%-1.07
17.88%-1.47
-13.67%-1.58
-7.95%-6.38
-4.72%-1.33
-21.57%-1.86
-9.82%-1.79
6.08%-1.39
-50.77%-5.91
-4.10%-1.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Jun 30, 2024(Q2)Mar 31, 2024(Q1)Dec 31, 2023(FY)Sep 30, 2023(Q4)Sep 30, 2023(Q3)Jun 30, 2023(Q2)Mar 31, 2023(Q1)Dec 31, 2022(FY)Sep 30, 2022(Q4)Sep 30, 2022
Total revenue -4.88%17.97M-4.16%17.05M-23.67%18M-8.07%79.2M-6.82%18.93M-3.01%18.89M-4.92%17.8M-14.70%23.59M-11.24%86.16M-13.82%20.32M
Operating revenue -4.88%17.97M-4.16%17.05M-23.67%18M-8.07%79.2M-6.82%18.93M-3.01%18.89M-4.92%17.8M-14.70%23.59M-11.24%86.16M-13.82%20.32M
Cost of revenue
Gross profit
Operating expense -24.19%42.16M-12.97%49.82M-1.32%52.89M3.05%216.41M5.48%49.96M6.89%55.61M8.91%57.25M-7.68%53.6M1.62%210M-17.34%47.37M
Selling and administrative expenses 6.31%13.41M3.32%14.24M30.10%16.52M16.28%52.89M9.75%13.8M-2.41%12.62M31.52%13.78M33.53%12.7M39.79%45.48M50.42%12.57M
-General and administrative expense 6.31%13.41M3.32%14.24M30.10%16.52M16.28%52.89M9.75%13.8M-2.41%12.62M31.52%13.78M33.53%12.7M39.79%45.48M50.42%12.57M
Research and development costs -33.14%28.74M-18.14%35.59M-11.08%36.37M-0.61%163.52M3.94%36.17M9.97%42.99M3.28%43.47M-15.75%40.9M-5.51%164.52M-28.91%34.8M
Operating profit 34.12%-24.19M16.95%-32.77M-16.24%-34.89M-10.79%-137.21M-14.72%-31.03M-12.82%-36.71M-16.56%-39.45M1.30%-30.01M-13.02%-123.84M19.80%-27.05M
Net non-operating interest income expense -39.43%1.13M-32.17%1.25M-13.70%857K294.91%6.21M139.78%1.51M375.57%1.87M620.39%1.84M993K-22.17%1.57M631K
Non-operating interest income -9.80%3.49M107.35%3.81M332.83%4.3M622.19%11.36M639.14%4.66M883.72%3.87M620.39%1.84M--993K-22.17%1.57M--631K
Non-operating interest expense 17.93%2.36M--2.56M--3.44M--5.15M--3.15M--2M--0--0--0--0
Other net income (expense) 407.41%83K
Other non- operating income (expenses) --------------------------------407.41%83K----
Income before tax 33.84%-23.05M16.20%-31.52M-17.26%-34.03M-7.21%-131M-12.09%-29.52M-8.39%-34.84M-11.97%-37.61M3.75%-29.02M-13.58%-122.19M21.14%-26.33M
Income tax -109.36%-395K-925.00%-363K-1,729.41%-622K751.50%2.82M-10,171.43%-1.41M1,044.30%4.22M44K5.56%-34K98.49%-433K100.16%14K
Net income 42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M-54.13%-121.76M-7.11%-26.35M
Net income continuous Operations 42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M-54.13%-121.76M-7.11%-26.35M
Minority interest income
Net income attributable to the parent company 42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M-54.13%-121.76M-7.11%-26.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 42.00%-22.66M17.26%-31.16M-15.25%-33.41M-9.91%-133.82M-6.68%-28.11M-23.23%-39.07M-12.10%-37.66M3.75%-28.99M-54.13%-121.76M-7.11%-26.35M
Basic earnings per share 42.47%-1.0717.88%-1.47-13.67%-1.58-7.95%-6.38-4.72%-1.33-21.57%-1.86-9.82%-1.796.08%-1.39-50.77%-5.91-4.10%-1.27
Diluted earnings per share 42.47%-1.0717.88%-1.47-13.67%-1.58-7.95%-6.38-4.72%-1.33-21.57%-1.86-9.82%-1.796.08%-1.39-50.77%-5.91-4.10%-1.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data